James Woodruff Lillie, Chief Scientific Officer at MapLight Therapeutics, Inc. (MPLT), sold 18,267 shares at $36.00 ($674K) on 2026-07-15, disclosed to the SEC on 2026-07-17.
Open-market sale of $674k MPLT by Chief Scientific Officer. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $36.00 | 2,238 | $81K | 12.0% |
| 2 | $36.99 | 5,393 | $199K | 29.6% |
| 3 | $37.54 | 12 | $450 | 0.1% |
| 4 | $36.45 | 5,009 | $183K | 27.1% |
| 5 | $37.26 | 3,526 | $131K | 19.5% |
| 6 | $37.96 | 12 |
| $456 |
| 0.1% |
| 7 | $37.90 | 2,077 | $79K | 11.7% |
| Total | $36.88 avg | 18,267 | $674K | 100% |
| Filing → |
| MPLT | SELL | 2026-05-06 | $1.5M | — | Filing → |
| MPLT | SELL | 2026-04-17 | $123K | — | Filing → |